Limited time offer on Zoomind. Buy two get one free!

(offer ends Sept 28)

Zoomind Product FAQ

Zoomind is a dietary supplement in capsule form that delivers phosphatidylserine, L-Tyrosine, and Omega-3. Zoomind was formulated to promote clarity and focus and support symptoms of ADHD. Zoomind is an over-the-counter natural health product designed for adults and children.

The recommended dose is two capsules daily with food. If the daily dose has not been taken, the missing dose can be supplemented the next day (up to a daily dose of 4 capsules). Always consult your doctor before taking Zoomind, especially if you (or your child) take other prescription medication.

Zoomind’s main ingredients are Phosphatidylserine, Omega 3 fatty acids, and L-tyrosine.

PS (Phosphatidylserine), Omega-3 fatty acids, and L-Tyrosine have been studied for their potential benefits in managing ADHD symptoms. Here are some potential benefits and relevant references for each:

Phosphatidylserine (PS):
PS is a naturally occurring phospholipid found in high concentrations in brain cell membranes.

Some studies suggest that PS supplementation may improve cognitive functions, attention, and behavior in individuals with ADHD.

One study conducted by Hirayama et al. (2014) found that PS supplementation improved attention, impulsivity, and short-term auditory memory in children with ADHD. Reference: Hirayama S, et al. (2014). The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial. Journal of Human Nutrition and Dietetics, 27(4), 284-291.

Omega-3 Fatty Acids:
Omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are essential fats found in fish oil.

Some studies suggest that omega-3 supplementation may positively impact ADHD symptoms, such as inattention, hyperactivity, and impulsivity.

One randomized controlled trial by Gustafsson et al. (2010) found that omega-3 supplementation improved attention and behavior in children with ADHD. Reference: Gustafsson PA, et al. (2010). Omega-3 fatty acids supplementation improves cognition and modifies brain activation in young children with attention deficit hyperactivity disorder. PLoS ONE, 5(11), e13917.

L-Tyrosine:

L-Tyrosine is an amino acid that is a precursor to dopamine, norepinephrine, and epinephrine, which are neurotransmitters involved in attention and mood regulation.

Some studies suggest that L-Tyrosine supplementation may enhance cognitive performance and attention in stressful or demanding situations.

One study conducted by Colzato et al. (2013) found that L-Tyrosine supplementation improved working memory performance in healthy adults under high-demanding conditions. Reference: Colzato LS, et al. (2013). Acute tyrosine supplementation improves working memory in older adults: evidence from a double-blind, placebo-controlled study. Neurobiology of Aging, 34(4), 1177-1187.

Omega-3 deficiencies are often associated with ADHD in children. Zoomind is rich in omega-3 fatty acids and phosphatidylserine, both associated with boosting brain power.

Zoomind provides a pure source of essential fatty acids that the body needs for a wide variety of functions. Just about every aspect of neurotransmission — the movement of information from brain cell to brain cell — is affected by omega-3s. Our bodies can’t produce omega-3 fatty acids on their own. Zoomind is specially designed to boost the volume of omega-3 fatty acids in the body.

Zoomind, natural ADHD supplement capsules do not contain sugar, lactose, yeast, or gluten. 

Ingredients and Serving Size 

L-Tyrosine USP Powder (NLT 98.5% & NMT 0.3% LOD) 250 mg 

Phosphatidylserine Powder (NLT 50% & NMT 2% LOD)(Allergen: Soy) 75 mg 

Omega-3 Fish Oil Powder 50% NR (Allergen: Fish) 5 mg Omega-3 

Microcel MC-112 Microcrystalline Cellulose 

Silicon Dioxide Powder (NLT 98% & NMT 7% LOD)

Zoomind contains fish and soy.

  1. Richardson, A.J., 0meqa-3 fatty acids in ADHD and related neu rod eve I op mental disorders. Irrt Rev Psychiatry, 2006. 13(2): p. 15W2.
  2. SanGiovanni, J.P., et al., Meta-analysis of dietary essential fatly acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics, 2000.105(6): p. 1292-8.
  3. Schuchardt, J.P., et al., Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur J Pediatr, 2010.169(2): p. 149-64.
  4. Kawashima, A., et al., Effects of eicosapentaenoic acid on synaptic plasticity. fatty acid profile and phosphoiinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells. J Nutr Biochern, 2010.21(4): p. 268-77.
  5. Martinez, M.„ Severe deficiency of docosahexaenoic acid in Beroxisomal disorders: a defect of delta 4 desaturation? eurology, 1990. 40(8): p. 1292-8.
  6. Soderberg, M., et al., Fatty acid composition of brain phospholipids in aqinq and in Alzheimer’s disease. Lipids, 1991.26(6): p. 421-5.
  7. Vaisman, N., Pelled, D., n-3 phosphatidyl serine attenuated scopolamine-induced amnesia in middle-aged rats. Prog Neuropsychopharmacol Biol Psychiatry, 2009.33(6): p. 952-9..
  8. Mozzi, R., Buratta, S., Goracci, G., Metabolism and functions of phosphatidylserine in mammalian brain. Neurochem Res, 2003. 28(2): p. 195-214.
  9. Wheeler, R.P.W., R., ATPase activity of the sodium pump needs of phosphatidylserine. Nature, 1970. 225(5231): p. 449-450.
  10. Bittova, L., Stahelin, R.V., Cho, W., Roles of ionic residues of the C1 domain in protein kinase C-alpha activation and the origin of phosphatidylserine specificity. J Biol Ghem. 2001. 276(6): p. 4218-26.
  11. Vance, J.E., Phosphatidylserine and Phosphatidylethanolamine in Mammalian Cells: Two Metabolically-related Aminophospholipids. ASBMB, 2008: p. 1-48.
  12. Pepeu, G., Pepeu, I.M.,Amaducci, L., A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain? Pharmacol Res, 1996.33(2): p. 73-80.
  13. Mazzari, S. and A. Battistella, Phosphatidylserine effects on dopamine release from striatum synaptosomes. In: Multidisciplinary Approach to Brain Development. Elsevier North Holland Amsterdam, 1980: p. 569-570.
  14. Tso, P., Intestinal lipid absorption. Physiology of the gastrointestinal tract, ed. L.R. Johnson. Vol. 56.1994, New York: Raven Press.
  15. Wise, E.M., Elwyn, D., Rates of reactions involved in phosphatide synthesis in liver and small intestine of intact rats. Journal of Biological Chemistry, 1965. 240: p. 1537-1548.
  16. Heywood, R., Cozens, D., Richold, M., Toxicology of a phosphatidylserine preparation from bovine brain. C. Trials Journal, 1987.24(1): p. 25-32.
  17. Manor, I. et al., The effect of phosphatidylserine containing omega-3 fatty-acids on attentiion-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension. Eur Psychiatry, 2012.27(5): p.335-42.
  18. Manor, I. et al., Safety of phosphatidylserine containing omega-3 fatty acids in ADHD children: A double-blind placebo-controlled trial followed by an open-label extension. Eur Psychiatry, 2013. Eur Psychiatry, 2013. 28(6):p. 386-91.

More Questions?